AnswerY helps client understand nuances behind HCP treatment rationale, boost their RWD research capabilities + inform strategic initiatives for smarter next steps.
Download PDF
The Ask
CLIENT
Global
Large BioPharma
Expand Data Gaps
Fill RWD knowledge gaps + enhance their NLP + ML models for deeper, more holistic insights.
Need Nuanced, Behind-The-Scenes Intel
Want a compliant, qualitative dataset that provides real insights into prescriber treatment rationale.
The Approach
TOOLS
AnswerY
Data Scientists
Double Down On Unique Data
Request additional HIPAA-compliant HCP patient notes after realizing value in raw oncology record samples.
Ongoing Education & Support
Conduct learning sessions and provide access to HIPAA-compliant database + platform, enabling their data scientists to query data + consult our experts.
Regularly Updated Data
Receive monthly data refreshes + send to internal data lake to maintain quality + integrity and ensure secure + easy access.
The Results
OUTCOME
Cost-Effective Research
Richer Insights
Client Satisfaction
Confirmed Tier 1 Status
Designated AnswerY as Tier 1, providing organization-wide access to support strategy development, competitive analysis, market research, and patient identification.
Context Revealed The "Why"
Access to prescriber-patient interactions helped brand leaders understand treatment responses + the impact of social health determinants.
Cost + Time Savings
Served as compliant + valuable supplement to existing RWD studies versus costly + resource-heavy market research.
Extended Data Partnership
Renewed AnswerY enterprise license 3 times to date.
